Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Switzerland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20071
20083
20091
20133
20141
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Swiss Cancer Institute2
AbbVie1
Bayer1
Centre Hospitalier Universitaire Vaudois1
Clovis Oncology, Inc.1
ETOP IBCSG Partners Foundation1
Genentech, Inc.1
NantCell, Inc.1
Novartis Pharmaceuticals1
Philogen S.p.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis13
Breast Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Neoplasms3
Recurrence2
Brain Neoplasms1
Colonic Neoplasms1
Colorectal Neoplasms1
Lung Neoplasms1
Melanoma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.